Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.260
-0.320 (-6.99%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $156.63 million as of March 31, 2025. Its market cap has increased by 275.61% in one year.
Market Cap
156.63M
Enterprise Value
-9.18M
1-Year Change
275.61%
Ranking
Category
Stock Price
$4.26
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has increased from $140.90M to $156.63M, an increase of 11.16%. That is a compound annual growth rate of 1.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 168.40M | 54.64% |
Dec 31, 2024 | 108.90M | 411.27% |
Dec 29, 2023 | 21.30M | -29.47% |
Dec 30, 2022 | 30.20M | -60.16% |
Dec 31, 2021 | 75.80M | -72.07% |
Dec 31, 2020 | 271.40M | 3,292.50% |
Dec 31, 2019 | 8.00M | -81.65% |
Dec 31, 2018 | 43.60M | 30.15% |
Dec 29, 2017 | 33.50M | 6.35% |
Dec 30, 2016 | 31.50M | -87.68% |
Dec 31, 2015 | 255.70M | 49.44% |
Dec 31, 2014 | 171.10M | 21.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |